A randomized controlled clinical trial of recombinant human alpha-2a interferon (IFN) in cryptogenic chronic active liver disease: Preliminary results

Autor: Diodati, C., Bonetti, P., Maladorno, D., Alberti, A., Realdi, G., Ruol, A.
Zdroj: In Journal of Hepatology 1989 9 Supplement 1:S26-S26
Databáze: ScienceDirect